News
Could this be a new era of preventative cancer medicine?
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Robbie Williams made headlines last month after revealing that he’d been diagnosed with scurvy, following rapid weight loss ...
22h
Health on MSNThis New Pill Could Rival Ozempic and Wegovy—Will It Make Weight Loss Drugs More Accessible?Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...
GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...
Explore more
4don MSN
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
3don MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results